MedPath

呼伦贝尔康益药业有限公司

Ownership
-
Established
2002-06-11
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

NMPA:23

Drug Approvals

Furazolidone Tablets

Product Name
呋喃唑酮片
Approval Number
国药准字H15020775
Approval Date
May 22, 2020
NMPA

Dipyridamole Tablets

Product Name
双嘧达莫片
Approval Number
国药准字H15020443
Approval Date
May 22, 2020
NMPA

Lacidophilin Tablets

Product Name
乳酸菌素片
Approval Number
国药准字H15020441
Approval Date
May 22, 2020
NMPA

Oxytetracycline Tablets

Product Name
土霉素片
Approval Number
国药准字H15020445
Approval Date
May 22, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H15020436
Approval Date
May 22, 2020
NMPA

Triamterene Tablets

Product Name
氨苯蝶啶片
Approval Number
国药准字H15020435
Approval Date
May 22, 2020
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H15020439
Approval Date
May 22, 2020
NMPA

Lacidophilin Tablets

Product Name
乳酸菌素片
Approval Number
国药准字H15020440
Approval Date
May 22, 2020
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H15020438
Approval Date
May 22, 2020
NMPA

Pediatric Compound SulfamethoxazoleTablets

Product Name
小儿复方磺胺甲噁唑片
Approval Number
国药准字H15020446
Approval Date
May 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.